Literature DB >> 25218969

Dihydrochalcones and homoisoflavanes from the red resin of Dracaena cochinchinensis (Chinese dragon's blood).

Xiao-Qin Su1, Yue-Lin Song2, Jing Zhang1, Hui-Xia Huo1, Zheng Huang1, Jiao Zheng2, Qian Zhang2, Yun-Fang Zhao2, Wei Xiao3, Jun Li4, Peng-Fei Tu5.   

Abstract

Two new dihydrochalcones, 4-hydroxy-2,4'-dimethoxydihydrochalcone (1) and 3,4'-dihydroxy-2,4,6-trimethoxydihydrochalcone (2), and a new homoisoflavane, 7,3'-dihydroxy-8,4'-dimethoxyhomoisoflavane (3), along with 12 known compounds (4-15), were isolated from the red resin of Dracaena cochinchinensis (Chinese dragon's blood). Their structures were assigned by a variety of spectroscopic techniques. Diversity of cleavage pathways were proposed for dihydrochalcones and homoisoflavanes based on the mass spectroscopic behaviors of those identified compounds using hybrid ion trap-time of flight mass spectrometry. All the compounds were evaluated for their inhibitory effects on nitric oxide production in lipopolysaccharide-induced RAW 264.7 macrophages, and compound 9 exhibited mild inhibition of NO production in this assay with IC₅₀ value of 50.3 μM.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2,4,4′-trihydroxydihydrochalcone (PubChem CID: 10801179); Chinese dragon's blood; Dihydrochalcone; Dracaena cochinchinensis; Homoisoflavane; Loureirin A (PubChem CID: 5319081); Loureirin B (PubChem CID: 189670); Loureirin C (PubChem CID: 14157896); Loureirin D (PubChem CID: 13939318); Mass fragmentation pathway

Mesh:

Substances:

Year:  2014        PMID: 25218969     DOI: 10.1016/j.fitote.2014.09.006

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  7 in total

Review 1.  Flavonoids and Stilbenoids of the Genera Dracaena and Sansevieria: Structures and Bioactivities.

Authors:  Zaw Min Thu; Ko Ko Myo; Hnin Thanda Aung; Chabaco Armijos; Giovanni Vidari
Journal:  Molecules       Date:  2020-06-03       Impact factor: 4.411

2.  Phytochemical analysis of Vietnamese propolis produced by the stingless bee Lisotrigona cacciae.

Authors:  Kristina Georgieva; Milena Popova; Lyudmila Dimitrova; Boryana Trusheva; Le Nguyen Thanh; Diep Thi Lan Phuong; Nguyen Thi Phuong Lien; Hristo Najdenski; Vassya Bankova
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

3.  Systems Pharmacology-Dissection of the Molecular Mechanisms of Dragon's Blood in Improving Ischemic Stroke Prognosis.

Authors:  Meng Jiang; Xing Su; Jianling Liu; Chunli Zheng; Xiaogang Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-17       Impact factor: 2.629

4.  Exploring in vitro anti-proliferative and anti-inflammatory activities of Prasachandaeng remedy, and its bioactive compounds.

Authors:  Nuntika Prommee; Arunporn Itharat; Pakakrong Thongdeeying; Sunita Makchuchit; Weerachai Pipatrattanaseree; Adis Tasanarong; Buncha Ooraikul; Neal M Davies
Journal:  BMC Complement Med Ther       Date:  2022-08-11

5.  Longxuetongluo Capsule Improves Erythrocyte Function against Lipid Peroxidation and Abnormal Hemorheological Parameters in High Fat Diet-Induced ApoE-/- Mice.

Authors:  Jiao Zheng; Binglin Liu; Qixing Lun; Weijuan Yao; Yunfang Zhao; Wei Xiao; Wenzhe Huang; Yonghua Wang; Jun Li; Pengfei Tu
Journal:  Oxid Med Cell Longev       Date:  2015-11-16       Impact factor: 6.543

6.  Rapid Evaluation of Chemical Consistency of Artificially Induced and Natural Resina Draconis Using Ultra-Performance Liquid Chromatography Quadrupole-Time-of-Flight Mass Spectrometry-Based Chemical Profiling.

Authors:  Qianping Chen; Lili He; Changming Mo; Zhifeng Zhang; Hairong Long; Xiaoyu Gu; Ying Wei
Journal:  Molecules       Date:  2018-07-25       Impact factor: 4.411

7.  Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms.

Authors:  Bo Pan; Jing Sun; Ziyu Liu; Lingxiao Wang; Huixia Huo; Yunfang Zhao; Pengfei Tu; Wei Xiao; Jiao Zheng; Jun Li
Journal:  J Adv Res       Date:  2021-02-09       Impact factor: 10.479

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.